Complete and limited duration cancer prevalence estimates. (Articolo in rivista)

Type

• Articolo in rivista (Classe)
• Prodotto della ricerca (Classe)

Label

• Complete and limited duration cancer prevalence estimates. (Articolo in rivista) (literal)

Anno

• 2002-01-01T00:00:00+01:00 (literal)

Alternative label

• Mariotto Angela, Gigli Anna, Capocaccia Riccardo, Tavilla Andrea, Clegg Limin X, Depry Michael, Scoppa Steve, Ries Lynn A.G., Rowland Julia H, Tesauro Gina, Feuer Eric J. (2002)
  Complete and limited duration cancer prevalence estimates.
  in SEER cancer statistics review; National Cancer Institute, Bethesda, MD (Stati Uniti d'America)
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• Mariotto Angela, Gigli Anna, Capocaccia Riccardo, Tavilla Andrea, Clegg Limin X, Depry Michael, Scoppa Steve, Ries Lynn A.G., Rowland Julia H, Tesauro Gina, Feuer Eric J. (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#titoloVolume

• SEER Cancer Statistics Review 1973-99 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

• 19 (literal)

Rivista

• SEER cancer statistics review (Rivista)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#note

• Disponibile all'indirizzo : (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

• Mariotto Angela : National Cancer Institute, National Institutes of Health, Bethesda, Usa Gigli Anna : IRPPS - CNR Tavilla Andrea : Istituto Superiore di Sanità, Roma Depry Michael : Information Management Services, Inc.,Silver Springer, USA (literal)

Titolo

• Complete and limited duration cancer prevalence estimates. (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autoriVolume

• National Cancer Institute (literal)

Abstract

• Prevalence is an indicator of primary interest in public health because it measures the burden of cancer in a population and on the health care system. Prevalence is defined as thenumber or percent of people alive on a certain date in a population who previously had a diagnosis of the disease. It includes new (incidence) and pre-existing cases and is a function of both past incidence and survival. Information on prevalence can be used for health planning,resource allocation and an estimate of cancer survivorship. In past reports of the Cancer Statistics Review, US cancer prevalence was estimated by multiplying the Connecticut cancer prevalence proportions to the US population. This year, US cancer prevalence is estimated by applying SEER-9 and SEER-11 prevalence proportions to the US population. SEER proportion rates are more representative of the US and permit estimation of prevalence by racial/ethnic groups. Other changes with respect to previous reports are in the methods for tumor inclusion and complete prevalence calculation. (literal)

Editore

• National Cancer Institute (Editore)

Prodotto di

• Dinamiche della Popolazione e Governance (IC.P08.003.001) (Modulo)
• Istituto di ricerche sulla popolazione e le politiche sociali (IRPPS) (Istituto)

Autore CNR

• ANNA GIGLI (Persona)

Incoming links:

Prodotto

• Istituto di ricerche sulla popolazione e le politiche sociali (IRPPS) (Istituto)
• Dinamiche della Popolazione e Governance (IC.P08.003.001) (Modulo)

Autore CNR di

• ANNA GIGLI (Persona)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• SEER cancer statistics review (Rivista)

Editore di

• National Cancer Institute (Editore)